At Aegis Growth Conference today it sounded like there was one guy in the audience but you got an earful if you listened to the company presentation (on their website soon I'm sure) and all the questions.
CEO said the data from their breast biopsy tests were obviously "exciting enough" to have them quickly start up a larger clinical trial. This data is embargoed now but will be announced in early December. Sounds like company has a big one-two punch with big data events in both DEC and JAN next. Then first product launch is on schedule for Q2 2017 which will begin to generate revenues.
News 
Market Data 
Discover 
